National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
EORTC QOL-OV39
Not yet recruiting
50 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
PROVE
Recruiting
1,300 enrolled
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
Recruiting
18 enrolled
THRIVE
Recruiting
1,000 enrolled
SCOUT-1
Recruiting
750 enrolled
HERO
Recruiting
1,000 enrolled
DP-04
Recruiting
100 enrolled
PARIB-OLD-PRO²
Recruiting
50 enrolled
BASECAMP-1
Recruiting
200 enrolled
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Recruiting
120 enrolled
Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy
Completed
43 enrolled
VEGF
Completed
613 enrolled
Healthy Volunteers Study
Recruiting
50 enrolled
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
Not yet recruiting
100 enrolled
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Recruiting
600 enrolled
OLIVIA
Recruiting
250 enrolled
Diet, Hepcidin, and Chemotherapy RDI
Active not recruiting
100 enrolled
SMARAGD
Recruiting
1,975 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
ECHO
Recruiting
3,110 enrolled
Visual-PC
Not yet recruiting
50 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
Terminated
22 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Active not recruiting
354 enrolled
Spectroscopy in Ovarian Cancer
Completed
160 enrolled